View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
January 28, 2020updated 13 Feb 2020 10:31am

Coronavirus: US FDA focuses on medical countermeasures

The US Food and Drug Administration (FDA) is set to form alliances to accelerate the development of medical countermeasures for the new coronavirus that emerged in Wuhan, China last month.


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates


Follow the latest updates of the outbreak on our timeline.

The US Food and Drug Administration (FDA) is set to form new alliances to accelerate the development of medical countermeasures for the new coronavirus that emerged in Wuhan, China last month.

The regulator will work with interagency and international partners, product developers and global regulators. The focus is to develop and make available medical products to treat, mitigate, prevent and diagnose such outbreaks.

FDA is sharing process updates to aid developers and issuing important information for the public to help in the development of medical products.

The coronavirus currently lacks diagnostics and the FDA is collaborating with public health partners to advance and share reference materials for diagnostic development.

FDA commissioner Stephen Hahn said: “We are actively leveraging the vast breadth of the FDA’s expertise and have begun employing the full range of our public health authorities to facilitate the development and availability of investigational medical products to help address this urgent public health situation.”

Meanwhile, Anti-Coronavirus Foundation has been established in Geneva, Switzerland to fund research for the development of a coronavirus vaccine.

To ensure transparency, the foundation will manage all transactions in CRON blockchain run by CryptOcean. Anyone can use the blockchain platform to send funds for research at the foundation.

Furthermore, information analytics company Elsevier has created a Novel Coronavirus Information Center, providing access to medical, clinical research and scientific information regarding the virus.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology